bcl-2 Inhibits mitochondrial metabolism and lonidamine-induced apoptosis in adriamycin-resistant MCF7 cells

International Journal of Cancer

Volumn 82, Issue 1, 1999, Pages 125-130

  Biroccio, Annamaria ^a   Del Bufalo, Donatella ^a   Fanciulli, Maurizio ^a   Bruno, Tiziana ^a   Zupi, Gabriella ^a   Floridi, Aristide ^a,b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; CARBON DIOXIDE; DOXORUBICIN; LONIDAMINE; PROTEIN BCL 2; PROTEIN P53;

ANTIBIOTIC RESISTANCE; APOPTOSIS; ARTICLE; BREAST CANCER; CALCIUM TRANSPORT; CELL ENERGY; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MITOCHONDRIAL RESPIRATION; MULTIDRUG RESISTANCE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENERGY METABOLISM; HUMANS; INDAZOLES; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033516635     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990702)82:1<125::AID-IJC21>3.0.CO;2-Q     Document Type: Article

References (23)

1. ADAMS, J.M. and CORY, S., The bcl-2 protein family: arbiters of cell survival. Science, 281, 1322-1326 (1998).
2. CASTIGLIONE, S., KENNEDY, K.A., FLORIDI, A. and FISKUM, G., Nonionophoretic elevation of intracellular Ca2+ by Lonidamine. Biochem. Pharmacol., 46, 330-332 (1993).
3. CITRO, G., CUCCO, C., VERDINA, A. and ZUPI, G., Reversal of adriamycin resistance by lonidamine in a human breast-cancer cell line. Brit. J. Cancer, 64, 534-536 (1991).
4. XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res., 57, 62-67 (1997).
5. DEL BUFALO, D., BIROCCIO, A., LEONETTI, C. and ZUPI, G., bcl-2 overexpression enhances the metastatic potential of a human breast-cancer line. FASEB J., 11, 947-953 (1997).
6. DEL BUFALO, D., BIROCCIO, A., SODDU, S., LAUDONIO, N., D'ANGELO, C., SACCHI, A. and ZUPI, G., Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene. J. clin. Invest., 98, 1165-1173 (1996).
7. FAIRCHILD, C.R. and COWAN, K.H., Multidrug resistance: a pleiotropic response to cytotoxic drugs. Int. J. Rad. Oncol. Biol. Phys., 20, 361-367 (1991).
8. FANCIULLI, M., BRUNO, T., CASTIGLIONE, S., DEL CARLO, C., PAGGI, M.G. and FLORIDI, A., Glucose metabolism in adriamycin-sensitive and -resistant LoVo human colon-carcinoma cells. Oncol. Res., 5, 357-362 (1993).
9. FANCIULLI, M., VALENTINI, A., BRUNO, T., CITRO, G., ZUPI, G. and FLORIDI, A., Effect of the antitumor drug lonidamine on glucose metabolism of adriamycin-sensitive and -resistant human breast-cancer cells. Oncol. Res., 8, 111-120 (1996).
10. FISHER, D.E., Apoptosis in cancer therapy: crossing the threshold. Cell, 78, 539-542 (1994).
11. FLORIDI, A., ALEXANDRE, A., PAGGI, M.G., PELLEGRINI, L., MARCANTE, M.L., SILVESTRINI, B., CAPUTO, A. and LEHNINGER, A.L. In: T. Galeotti (eds.), Cell membranes and cancer, Elsevier Science, (1985).
12. FLORIDI, A. and LEHNINGER, A.L., Action of the antitumor and antispermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria. Arch. Biochem. Biophys., 266, 73-83 (1983).
13. FLORIDI, A., PAGGI, M.G., D'ATRI, S., DE MARTINO, C., MARCANTE, M.L., SILVESTRINI, B. and CAPUTO, A., Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res., 41, 4661-4666 (1981).
14. GREEN, D.R. and REED, J.C., Mitochondria and apoptosis. Science, 281, 1309-1312 (1998).
15. KNUDSON, C.M. and KORSMEYER, S.J., bcl-2 and bax function independently to regulate cell death. Nature Genet., 16, 358-363 (1997).
16. KORSMEYER, S.J., bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood, 80, 879-886 (1992).
17. KRAJEWSKI, S., TANAKA, S., TAKAYAMA, S., SCHIBLER, M.J., FENTON, W. and REED, J.C., Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res., 53, 4701-4714 (1993).
18. MARTON, A., MIHALIK, R., BRATINCSAK, A., ADLEFF, V., PETÁK, I., VÉGH, M., BAUER, P.I. and KRAJCSI, P., Apoptotic cell death induced by inhibitors of energy conservation-bcl-2 inhibits apoptosis downstream of a fall of ATP level. Europ. J. Biochem., 250, 467-475 (1997).
19. NEWMEYER, D., FARSCHON, D. and REED, J., Cell-free apoptosis in Xenopus egg extracts: bcl-2 inhibits a latent cytoplasmic phase. Cell, 79, 353-364 (1994).
20. XL or bax proteins in multidrug-resistant MCF-7/Adr human breast-cancer cells. Int. J. Cancer. 67, 608-614 (1996).
21. OLTVAI, Z. and KORSMEYER, S., Checkpoints of dueling dimers foil death wishes. Cell, 79, 189-192 (1994).
22. 2 solubility in aqueous media determined by kinetic method. Anal. Biochem., 45, 430-450 (1985).
23. WILLIAMS, G.T. and SMITH, C.A., Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74, 777-779 (1993).